Allison

But the new GLP-1 agonist obesity and diabetes fighters took up more rungs on Milliman's list of top cash eaters.

But a rating agency expects the new weight loss drugs to reduce spending on bariatric surgery.

Viking Therapeutics' dual-action contender could add to pharmacy benefits cost pressure.

Bernie Sanders' committee voted 20-1 to investigate the hospital company and 16-4 for the subpoena.

Rep. Nick Langworthy asked about duty of care at a committee hearing featuring three top PBM executives.

A new report also reveals how much sicker platinum plan enrollees really are.

Employers may be doing better than other payers at holding costs down.

One provision would keep PBMs from steering enrollees toward their mail-order pharmacies.